title: Perinatal outcome after in-vitro fertilization-surrogacy.
abstract: The perinatal outcome of pregnancies (both single and multiple) established after in-vitro fertilization (IVF)-surrogacy was evaluated and compared to the outcome of pregnancies that resulted from standard IVF. Analysis of medical records and a telephone interview with physicians, IVF-surrogates, and commissioning mothers were conducted to assess prenatal follow up and delivery care in several hospitals. 95 IVF-surrogates delivered 128 liveborn (65 singletons, 27 sets of twins and two sets of triplets). The commissioning mothers and the IVF-surrogates average ages were 37.7 +/- 5.0 and 30.4 +/- 4.7 years old respectively. IVF-surrogates carrying twin and triplet gestations delivered substantially earlier than those who gestated singleton pregnancies (36.2 +/- 0.4 versus 35.5 versus 38.7 +/- 0.3 weeks gestation respectively; P < 0.001). Twin newborns were significantly lighter than singleton infants born through IVF-surrogacy (2.7 +/- 0.06 versus 3.5 +/- 0.07 kg; P < 0.001). The incidence of low birth weight infants rose from 3.3% in the single births to 29.6% (P < 0.01) in the twins and to 33.3% in the triplets born through IVF-surrogacy. The incidence of prematurity was significantly greater in both twins delivered by IVF-surrogates (20.4%) and infertile IVF patients (58%). The occurrence of pregnancy-induced hypertension and bleeding in the third trimester was four to five times lower in the IVF-surrogates, independently of whether they were carrying multiples. The incidence of Caesarean section was 21.3% for singleton gestations, while two times higher in the IVF-surrogates carrying multiples (56.3%). Postpartum complications occurred in 6.3% of patients and the incidence of malformation was similar to those reported for the general population. The results provide general reassurance regarding perinatal outcome to couples who wish to pursue IVF-surrogacy.
authors.affiliation: Huntington Reproductive Center, Pasadena, California, USA.
authors.forename: J
authors.initials: J
authors.lastname: Parkinson
authors.forename: C
authors.initials: C
authors.lastname: Tran
authors.forename: T
authors.initials: T
authors.lastname: Tan
authors.forename: J
authors.initials: J
authors.lastname: Nelson
authors.forename: J
authors.initials: J
authors.lastname: Batzofin
authors.forename: P
authors.initials: P
authors.lastname: Serafini
mesh_terms: D000328:Adult; D001724:Birth Weight; D002585:Cesarean Section; D000013:Congenital Abnormalities / Q000453:epidemiology; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro; D005865:Gestational Age; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011256:Pregnancy Outcome; D018607:Pregnancy Reduction, Multifetal; D011644:Puerperal Disorders / Q000453:epidemiology; D013533:Gestational Carriers; D014310:Triplets; D014427:Twins